Patent · US Active

Minigene expression cassette

US8129510B2 · kind B2 · utility

8Cited by
2References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 30, 2007
Grant dateMar 6, 2012
Priority date
Expiry dateMar 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/85
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for expressing a gene or nucleotide sequence of interest are provided. The compositions include an expression cassette that includes a synthetic enhancer, a transthyretin promoter, and a nucleotide sequence operably under the control of the synthetic enhancer and the transthyretin promoter. The expression cassette may be used in an adeno-associated viral (AAV) vector, such as a self-complementary AAV vector.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.